EMEA-001205-PIP02-19-M01
Key facts
| Active substance |
Tecovirimat (monohydrate)
|
| Therapeutic area |
Infectious diseases
|
| Decision number |
P/0496/2021
|
| PIP number |
EMEA-001205-PIP02-19-M01
|
| Pharmaceutical form(s) |
|
| Condition(s) / indication(s) |
Treatment of orthopoxvirus disease (smallpox, monkeypox, cowpox, and vaccinia)
|
| Route(s) of administration |
|
| Contact for public enquiries |
SIGA Technologies, Inc.
E-mail: PLong@siga.com |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|